{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:21:14Z","timestamp":1790889674312,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.jss.2011.10.013","type":"journal-article","created":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T11:38:47Z","timestamp":1320752327000},"page":"696-700","source":"Crossref","is-referenced-by-count":12,"title":["Protective Effect of Pharmacologic Preconditioning with Pioglitazone on Random-Pattern Skin Flap in Rat is Mediated by Nitric Oxide System"],"prefix":"10.1016","volume":"176","author":[{"given":"Sajjad","family":"Afraz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Moazzami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behtash G.","family":"Nezami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2011.10.013_bib1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/00006534-198312000-00003","article-title":"Skin flap failure: Pathophysiology","volume":"72","author":"Kerrigan","year":"1983","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jss.2011.10.013_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/alp.37.1.10.13","article-title":"Efficacy of topical nitroglycerin and transcutaneous electrical nerve stimulation on survival of random-pattern skin flaps in rats","volume":"37","author":"Atalay","year":"2003","journal-title":"Scand J Plast Reconstr Surg Hand Surg"},{"key":"10.1016\/j.jss.2011.10.013_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bjps.2004.06.001","article-title":"Preconditioning of the rat random-pattern skin flap: Modulation by opioids","volume":"58","author":"Kiumehr","year":"2005","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.jss.2011.10.013_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1054\/bjps.2000.3470","article-title":"Preconditioning of the distal portion of a rat random-pattern skin flap","volume":"54","author":"Matsumura","year":"2001","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.jss.2011.10.013_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00006534-200301000-00045","article-title":"Preconditioning of latissimus dorsi muscle flaps with monophosphoryl lipid a","volume":"111","author":"Maldonado","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jss.2011.10.013_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.SAP.0000037261.84618.7F","article-title":"Dual preconditioning: Effects of pharmacological plus ischemic preconditioning on skin flap survival","volume":"50","author":"Hosnuter","year":"2003","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jss.2011.10.013_bib7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.sap.0000258982.86308.f0","article-title":"Pharmacologic preconditioning of random-pattern skin flap in rats using local cyclosporine and FK-506: Interaction with nitric oxide system","volume":"59","author":"Nezami","year":"2007","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jss.2011.10.013_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/archfaci.1.1.27","article-title":"Comparison of topical anti-ischemic agents in the salvage of failing random-pattern skin flaps in rats","volume":"1","author":"Davis","year":"1999","journal-title":"Arch Facial Plast Surg"},{"key":"10.1016\/j.jss.2011.10.013_bib9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0026-0495(95)90056-X","article-title":"Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL\/KsJ-db\/db mice","volume":"44","author":"Fujiwara","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.jss.2011.10.013_bib10","doi-asserted-by":"crossref","first-page":"34J","DOI":"10.1016\/S0002-9149(03)00614-3","article-title":"The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis","volume":"92","author":"Plutzky","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jss.2011.10.013_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/713782132","article-title":"Glitazones: Clinical effects and molecular mechanisms","volume":"34","author":"Stumvoll","year":"2002","journal-title":"Ann Med"},{"key":"10.1016\/j.jss.2011.10.013_bib12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nri912","article-title":"Emerging roles of PPARs in inflammation and immunity","volume":"2","author":"Daynes","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jss.2011.10.013_bib13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ejcts.2003.12.017","article-title":"Protective effects of pre-ischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-\u03b3 ligand, on lung ischemia-reperfusion injury in rats","volume":"25","author":"Ito","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jss.2011.10.013_bib14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1096\/fj.01-0793com","article-title":"Ligands of the peroxisome proliferator-activated receptors (PPAR-\u03b3 and PPAR-\u03b1) reduce myocardial infarct size","volume":"16","author":"Wayman","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.jss.2011.10.013_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1471-4159.2006.03758.x","article-title":"Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-\u03b3 agonist rosiglitazone","volume":"97","author":"Luo","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.jss.2011.10.013_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000072088","article-title":"Agonists of peroxisome-proliferator activated receptor-\u03b3 reduce renal ischemia\/reperfusion injury","volume":"23","author":"Sivarajah","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jss.2011.10.013_bib17","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.cardiores.2004.12.008","article-title":"Beneficial effects of PPAR-\u03b3 ligands in ischemia-reperfusion injury, inflammation and shock","volume":"65","author":"Abdelrahman","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jss.2011.10.013_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/01.sap.0000214872.13634.d4","article-title":"ATP-sensitive potassium channels mediate the anti-ischemic properties of ischemic and pharmacologic preconditioning in rat random-pattern skin flap","volume":"57","author":"Beheshtian","year":"2006","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jss.2011.10.013_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bjps.2006.07.004","article-title":"Effects of nitric oxide synthase inhibition on blood flow and survival in experimental skin flaps","volume":"60","author":"Gribbe","year":"2007","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jss.2011.10.013_bib20","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1161\/hc4601.099403","article-title":"In\u00a0vivo myocardial protection from ischemia\/reperfusion injury by the peroxisome proliferator-activated receptor-\u03b3 agonist rosiglitazone","volume":"104","author":"Yue","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2011.10.013_bib21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/gast.2001.21191","article-title":"Endogenous PPAR \u03b3 mediates anti-inflammatory activity in murine ischemia-reperfusion injury","volume":"120","author":"Nakajima","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jss.2011.10.013_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1179\/135100002125000956","article-title":"specific peroxisome proliferator-activated receptor-\u03b3 (PPAR-\u03b3) ligand, pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats","volume":"7","author":"Ichikawa","year":"2002","journal-title":"Redox Rep"},{"key":"10.1016\/j.jss.2011.10.013_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/1523-1747.ep12328204","article-title":"Inhibitors of nitric oxide synthase in human skin","volume":"106","author":"Goldsmith","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jss.2011.10.013_bib24","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/00006534-199710000-00023","article-title":"The protective effect of L-arginine on ischemia-reperfusion injury in rat skin flaps","volume":"100","author":"Cordeiro","year":"1997","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jss.2011.10.013_bib25","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/01.ATV.0000177805.65864.d4","article-title":"Peroxisome proliferator-activated receptor \u03b3 ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor \u03b3-dependent mechanisms","volume":"25","author":"Polikandriotis","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jss.2011.10.013_bib26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cardiores.2004.11.027","article-title":"The effects of PPAR-\u03b3 ligand pioglitazone on platelet aggregation and arterial thrombus formation","volume":"65","author":"Li","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jss.2011.10.013_bib27","first-page":"219","article-title":"PPAR-\u03b3\u2014An important regulator of monocyte\/macrophage function","volume":"51","author":"von Knethen","year":"2003","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.jss.2011.10.013_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35154","article-title":"PPAR-\u03b3 agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480411008419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480411008419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T14:28:48Z","timestamp":1543415328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480411008419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0022480411008419"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2011.10.013","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}